By Josh White
Date: Thursday 14 Dec 2023
(Sharecast News) - Medical cannabis specialist Celadon Pharmaceuticals has started supplying its pharmaceutical-grade product to two commercial contracts, first announced on 24 May and 5 September, it said on Thursday.
By Josh White
Date: Friday 13 Jan 2023
(Sharecast News) - Celadon Pharmaceuticals updated the market on the arrival of its new finance chief on Friday.
By Josh White
Date: Thursday 22 Dec 2022
(Sharecast News) - Cannabis-based medicine developer Celadon Pharmaceuticals updated the market on its application for registration of its West Midlands facility with the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the 'Good Manufacturing Practices' (GMP) approval of its cannabis active pharmaceutical ingredient (API).
Currency | UK Pounds |
Share Price | 102.50p |
Change Today | -2.50p |
% Change | -2.38 % |
52 Week High | 172.50 |
52 Week Low | 79.00 |
Volume | 42,693 |
Shares Issued | 64.21m |
Market Cap | £65.81m |
RiskGrade | 111 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:08 | 25,000 @ 101.20p |
17:06 | 8,000 @ 102.50p |
14:07 | 9 @ 105.00p |
14:07 | 238 @ 105.00p |
14:07 | 1 @ 105.00p |
CEO | James Short |
CFO | Jonathan Turner |
You are here: research